Title: Benešová M, et al. Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer. J Nucl Med. 2015 Jun;56(6):914-20.
1507930-57-5
261969-05-5
114577-12-7
23642-44-6
54925-87-0
61393-34-8
1467093-03-3 | N-(5-(3-(7-(3-Fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide | AA01EO43 | MFCD30489411
1807988-47-1 | IITZ-01 | AA01EO7T | MFCD31746904
1443373-17-8 | AM-2099 | AA01EOF5 | MFCD30738047
1144477-35-9 | TM-N1324 | AA01EOK1 | MFCD12213621
1883727-34-1 | AMG-176 | AA01EONW | MFCD31747169
1952336-78-5 | 5-[3-(4-hydroxybenzoyl)-1H-indol-1-yl]-2-pentanone | AA01EOXN
2222132-40-1 | guanylyl-(3'→5')-3'-guanylicacid,cyclicnucleotide,disodiumsalt | AA01EP7W | MFCD28580125
853400-67-6 | N-[2-[2-[2-[bis(carboxymethyl)amino]-5-(2,7-dichloro-6-hydroxy-3-oxo-3H-xanthen-9-yl)phenoxy]ethoxy]-4-methylphenyl]-N-(carboxymethyl)-glycine,pentapotassiumsalt | AA01EPGG
126062-19-9 | 7-Amino-4-chloro-3-propoxy-1H-isochromen-1-one | AA01EPLR | MFCD22378306
136560-76-4 | N-[(9Z)-1-oxo-9-octadecen-1-yl]-L-leucine | AA01EPSC